Showing results (61-70 of 97) with videos related to
Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapyP Hadji, C Jackisch, W Bolten, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2014
Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH studyC Jackisch, S-B Kim, V Semiglazov, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 14, 2005
The role of surgery in recurrent ovarian cancerJ Pfisterer, P Harter, U Canzler, et al.Seminars in Oncology|August 1, 1997
Carboplatin plus paclitaxel as first-line chemotherapy in previously untreated advanced ovarian cancer. German AGO Study Group Ovarian Cancer. Arbeitsgemeinschaft Gynäkologische OnkologieA du Bois, H J Lück, W Meier, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Chemotherapy versus hormonal treatment in platinum- and paclitaxel-refractory ovarian cancer: a randomised trial of the German Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group Ovarian CancerBois A du, W Meier, H J Lück, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 29, 2006
The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVARJ Pfisterer, A du Bois, J Sehouli, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot studyG von Minckwitz, J-U Blohmer, G Raab, et al.Gynecologic Oncology|January 22, 2005
A phase II study of paclitaxel, carboplatin, and gemcitabine in previously untreated patients with epithelial ovarian cancer FIGO stage IC-IV (AGO-OVAR protocol OVAR-8)A du Bois, A Belau, U Wagner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2001
Dose-dense doxorubicin, docetaxel, and granulocyte colony-stimulating factor support with or without tamoxifen as preoperative therapy in patients with operable carcinoma of the breast: a randomized, controlled, open phase IIb studyG von Minckwitz, S D Costa, G Raab, et al.Human Mutation|March 25, 1999
Peutz-Jeghers syndrome: four novel inactivating germline mutations in the STK11 gene. Mutations in brief no. 227. OnlineR Kruse, S Uhlhaas, C Lamberti, et al.Pageof 10